This research examines how varying dosage levels and administration schedules impact treatment outcomes in clinical trials. The goal is to identify dosing strategies that maximize therapeutic benefit while minimizing adverse effects, supporting both patient safety and treatment effectiveness.

By analyzing pharmacokinetic and pharmacodynamic data alongside clinical outcomes, researchers gain insight into dose–response relationships. These findings play a critical role in shaping later-phase trial designs and guiding regulatory submissions.